Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Final Analysis of a Phase 1b Study of Daratumumab in Combination with Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma (RRMM)

Ajai Chari, MD, Sagar Lonial, Joaquin Martinez-Lopez, MD PhD, Maria-Victoria Mateos, Joan Bladé, MD PhD, Lotfi Benboubker, MD, Albert Oriol, Paula Rodriguez Otero, Luis Pineiro, Andrzej Jakubowiak, MD PhD, Yunsi Olyslager, Jianping Wang, Ivo Nnane, Jon Ukropec, PhD, Martin Shreeve, Ming Qi, MD PhD, Philippe Moreau, MD

Blood (2019) 134 (Supplement_1): 1876.

https://doi.org/10.1182/blood-2019-123539

Published: 2019

Journal Articles

Acute Myeloid Leukaemia in Children: Preliminary Results of a National Protocol in Casablanca, Morocco

Nabila Chellakhi, Nissrine Khoubila, Siham Cherkaoui, MD, Abdallah Madani, MD, Uma Athale, Asmaa AQ Quessar, MD

Blood (2015) 126 (23): 4898.

https://doi.org/10.1182/blood.V126.23.4898.4898

Published: 2015

Journal Articles

Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCyd) in Elderly Newly Diagnosed Multiple Myeloma Patients: Results of a Phase 2 Study

Sara Bringhen, Davide Rossi, MD PhD, Alessandra Larocca, Paolo Corradini, Piero Galieni, Alessandra Malfitano, Simona Aschero, Massimo Offidani, Anna Marina Liberati, Mariella Genuardi, Gianluca Gaidano, Carmela Palladino, Fabiana Gentilini, Mario Boccadoro, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo

Blood (2015) 126 (23): 1828.

https://doi.org/10.1182/blood.V126.23.1828.1828

Published: 2015

Journal Articles

Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCd) in Newly Diagnosed Multiple Myeloma Patients: A Phase I- II Study

Antonio Palumbo, MD, Davide Rossi, MD PhD, Sara Bringhen, MD, Alessandra Larocca, MD, Fabiana Gentilini, MDPhD, Lorenzo De Paoli, Paola Omedè, PhD, Stelvio Ballanti, MD, Federica Cavallo, MD, Roberto Passera, Anna Marina Liberati, MD, Mario Boccadoro, MD, Gianluca Gaidano, Pieter Sonneveld, MDPhD, Paolo Corradini, MD

Blood (2014) 124 (21): 175.

https://doi.org/10.1182/blood.V124.21.175.175

Published: 2014

Journal Articles

Heart MRI Identifies Patients At Higher Risk For Severe Pulmonary Edema After Bortezomib Plus Dexamethasone Treatment In Subclinical Heart Amyloidosis

Matthew Zheng, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 5330.

https://doi.org/10.1182/blood.V122.21.5330.5330

Published: 2013

Journal Articles

A Phase Ib Trial of Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL): The Ro-CHOP Study

Jehan Dupuis, MD, Rene-Olivier Casasnovas, MD, Herve Ghesquieres, MD, PhD, Franck Morschhauser, MD, PhD, Herve Tilly, Catherine Thieblemont, MD, PhD, Vincent Ribrag, MD, Bertrand Coiffier, MD, PhD

Blood (2012) 120 (21): 1617.

https://doi.org/10.1182/blood.V120.21.1617.1617

Published: 2012

Journal Articles

Preoperative Transfusion Practices and Outcomes in Sickle Cell Patients Admitted to California Hospitals,

Susan Claster, MD, Sheree M Schrager, MS, PhD, Vanessa Guzman, Julie Wolfson, MD, MSHS, Ellen Iverson, MPH

Blood (2011) 118 (21): 4189.

https://doi.org/10.1182/blood.V118.21.4189.4189

Published: 2011

Journal Articles

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Tetsuya Tanimoto, MD, Yasuo Oshima, MD, PhD, FACP, Koichiro Yuji, M.D., Ph.D., Masahiro Kami, MD, PhD

Blood (2011) 118 (21): 1698.

https://doi.org/10.1182/blood.V118.21.1698.1698

Published: 2011

Journal Articles

Use of Transfusion to Treat Acute Chest In Sickle Cell Disease:California Hospital Practice Patterns

Susan Claster, MD, Ellen Iverson, MPH, Sheree M Schrager, MS, PhD, Vanessa Guzman, Julie Wolfson, MD, MSHS

Blood (2010) 116 (21): 253.

https://doi.org/10.1182/blood.V116.21.253.253

Published: 2010

Journal Articles

Clinical Implications of Anemia in Heart Failure (HF) Patients (pts).

Dolores Puente, MD, Cecilia Colorio, MD, Roxana Ratto, MD, Martin Descalzo, MD, Andrea Rossi, MD, Francisco Perea, MD, Mirta Diez, MD, Ricardo Forastiero, Maria Tabares, MD, Liliana Favaloro, MD, Gonzalo Pombo, MD, Leonardo Feldman, MD

Blood (2007) 110 (11): 3776.

https://doi.org/10.1182/blood.V110.11.3776.3776

Published: 2007

Journal Articles

Bone Marrow Stem Cells Infusion in Treatment of Patients with Acute Myocardial Infarction.

Lidia Gil, PhD, Anna Czyz, PhD, Krzysztof Sawinski, PhD, Maria Kozlowska-Skrzypczak, PhD, Mieczyslaw Komarnicki, PhD, Stefan Grajek, PhD, Maciej Lesiak, PhD, Malgorzata Popiel, PhD, Piotr Breborowicz, PhD, Andrzej Cieslinski, PhD, Rafal Czepczynski, PhD, Jerzy Sowinski, PhD, Jan Styczynski, PhD

Blood (2006) 108 (11): 1682.

https://doi.org/10.1182/blood.V108.11.1682.1682

Published: 2006

Journal Articles

5-Azacytidine in the Treatment of High Risk Myelodysplastic Syndromes: Clinical Response Can Occur without Demethylation of the CDKN2B , CDKN1A or TP73 Gene Promoters.

Kavita Raj, MD, Alison John, PhD, Aloysius Ho, MD, Nicholas Shaun B. Thomas, PhD, Ghulam J. Mufti, MD

Blood (2004) 104 (11): 2369.

https://doi.org/10.1182/blood.V104.11.2369.2369

Published: 2004

NARROW

Final Analysis of a Phase 1b Study of Daratumumab in Combination with Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma (RRMM)

Acute Myeloid Leukaemia in Children: Preliminary Results of a National Protocol in Casablanca, Morocco

Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCyd) in Elderly Newly Diagnosed Multiple Myeloma Patients: Results of a Phase 2 Study

Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCd) in Newly Diagnosed Multiple Myeloma Patients: A Phase I- II Study

Heart MRI Identifies Patients At Higher Risk For Severe Pulmonary Edema After Bortezomib Plus Dexamethasone Treatment In Subclinical Heart Amyloidosis

A Phase Ib Trial of Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL): The Ro-CHOP Study

Preoperative Transfusion Practices and Outcomes in Sickle Cell Patients Admitted to California Hospitals,

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Use of Transfusion to Treat Acute Chest In Sickle Cell Disease:California Hospital Practice Patterns

Clinical Implications of Anemia in Heart Failure (HF) Patients (pts).

Bone Marrow Stem Cells Infusion in Treatment of Patients with Acute Myocardial Infarction.

5-Azacytidine in the Treatment of High Risk Myelodysplastic Syndromes: Clinical Response Can Occur without Demethylation of the CDKN2B , CDKN1A or TP73 Gene Promoters.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only